TCF12transcription factor 12
Autism Reports / Total Reports
8 / 10Rare Variants / Common Variants
29 / 0Aliases
-Associated Syndromes
-Chromosome Band
15q21.3Associated Disorders
-Relevance to Autism
Trio-based whole-exome sequencing of 168 patients with low-functioning ASD at Sun Yat-sen Memorial Hospital in Wu et al., 2025 identified a de novo loss-of-function variant in the TCF12 gene in a patient clinically diagnosed with ASD based on DSM-5 criteria and presenting with global developmental delay/intellectual disability. Additional de novo loss-of-function variants, as well as a de novo missense variant prediced to be deleterious by CADD, REVEL, and MPC, were previously reported in TCF12 in ASD probands from the MSSNG cohort, the SPARK cohort, and the Autism Sequencing Consortium (Yuen et al., 2016; Zhou et al., 2022; Fu et al., 2022; Trost et al., 2022). TCF12 was identified in Wang et al., 2020 as an novel NDD risk gene, with ultra-rare likely gene-disruptive variants reaching FDR significance following a combined analysis of new ASD and NDD cases with published data. Autism spectrum disorder was been reported in a subset of individuals with craniosynostosis 3 (Sharma et al., 2013; Paumard-Hernndez et al., 2015).
Molecular Function
The protein encoded by this gene is a member of the basic helix-loop-helix (bHLH) E-protein family that recognizes the consensus binding site (E-box) CANNTG. This encoded protein is expressed in many tissues, among them skeletal muscle, thymus, B- and T-cells, and may participate in regulating lineage-specific gene expression through the formation of heterodimers with other bHLH E-proteins. Heterozygous mutations in this gene are responsible for craniosynostosis 3 (OMIM 615314).
External Links
SFARI Genomic Platforms
Reports related to TCF12 (10 Reports)
| # | Type | Title | Author, Year | Autism Report | Associated Disorders |
|---|---|---|---|---|---|
| 1 | Support | - | Vikram P Sharma et al. (2013) | No | ASD |
| 2 | Support | - | Beatriz Paumard-Hernández et al. (2015) | No | ASD |
| 3 | Support | Genome-wide characteristics of de novo mutations in autism | Yuen RK et al. (2016) | Yes | - |
| 4 | Support | Large-scale targeted sequencing identifies risk genes for neurodevelopmental disorders | Wang T et al. (2020) | Yes | ID |
| 5 | Support | - | Zhou X et al. (2022) | Yes | - |
| 6 | Support | - | Fu JM et al. (2022) | Yes | - |
| 7 | Support | - | Chan AJS et al. (2022) | Yes | - |
| 8 | Support | - | Trost B et al. (2022) | Yes | - |
| 9 | Primary | - | Ruohao Wu et al. (2025) | Yes | - |
| 10 | Support | - | Giancarlo Mancuso et al. (2026) | Yes | - |
Rare Variants (29)
| Status | Allele Change | Residue Change | Variant Type | Inheritance Pattern | Parental Transmission | Family Type | PubMed ID | Author, Year |
|---|---|---|---|---|---|---|---|---|
| c.446C>G | p.Ser149Ter | stop_gained | Unknown | - | - | 33004838 | Wang T et al. (2020) | |
| c.921C>A | p.Tyr307Ter | stop_gained | De novo | - | - | 33004838 | Wang T et al. (2020) | |
| c.1876C>T | p.Arg626Ter | stop_gained | Unknown | - | - | 33004838 | Wang T et al. (2020) | |
| c.390+1G>A | p.? | splice_site_variant | De novo | - | - | 33004838 | Wang T et al. (2020) | |
| c.590C>T | p.Pro197Leu | missense_variant | Unknown | - | - | 33004838 | Wang T et al. (2020) | |
| c.616C>T | p.Arg206Cys | missense_variant | Unknown | - | - | 33004838 | Wang T et al. (2020) | |
| c.931delT | p.Ser311fs | frameshift_variant | De novo | - | - | 35982160 | Fu JM et al. (2022) | |
| c.1018G>C | p.Gly340Arg | missense_variant | Unknown | - | - | 33004838 | Wang T et al. (2020) | |
| c.1094G>A | p.Gly365Glu | missense_variant | Unknown | - | - | 33004838 | Wang T et al. (2020) | |
| c.1454G>A | p.Arg485Gln | missense_variant | Unknown | - | - | 33004838 | Wang T et al. (2020) | |
| c.1486G>T | p.Asp496Tyr | missense_variant | Unknown | - | - | 33004838 | Wang T et al. (2020) | |
| c.1838G>A | p.Arg613His | missense_variant | Unknown | - | - | 33004838 | Wang T et al. (2020) | |
| c.2027A>G | p.Glu676Gly | missense_variant | Unknown | - | - | 33004838 | Wang T et al. (2020) | |
| c.1433C>G | p.Ser478Ter | stop_gained | De novo | - | Simplex | 36368308 | Trost B et al. (2022) | |
| c.1036-1G>T | p.? | splice_site_variant | Familial | Maternal | - | 33004838 | Wang T et al. (2020) | |
| c.1189-2A>G | p.? | splice_site_variant | Familial | Maternal | - | 33004838 | Wang T et al. (2020) | |
| c.1837C>T | p.Arg613Cys | missense_variant | De novo | - | Simplex | 35982159 | Zhou X et al. (2022) | |
| c.953G>A | p.Gly318Glu | missense_variant | Familial | Paternal | - | 33004838 | Wang T et al. (2020) | |
| c.694del | p.His232ThrfsTer13 | frameshift_variant | De novo | - | - | 33004838 | Wang T et al. (2020) | |
| c.1877G>A | p.Arg626Gln | missense_variant | De novo | - | Multiplex | 33004838 | Wang T et al. (2020) | |
| c.281delA | p.His94LeufsTer10 | frameshift_variant | De novo | - | - | 41127290 | Ruohao Wu et al. (2025) | |
| c.686-1G>C | - | splice_site_variant | De novo | - | Simplex | 41596607 | Giancarlo Mancuso et al. (2026) | |
| c.160delA | Arg54GlufsTer33 | frameshift_variant | De novo | - | Simplex | 27525107 | Yuen RK et al. (2016) | |
| c.1099C>T | p.Pro367Ser | missense_variant | Familial | Maternal | Simplex | 33004838 | Wang T et al. (2020) | |
| c.1704del | p.Ser569ProfsTer22 | frameshift_variant | De novo | - | Simplex | 35982159 | Zhou X et al. (2022) | |
| c.356del | p.Leu119ArgfsTer16 | frameshift_variant | De novo | - | Multiplex | 33004838 | Wang T et al. (2020) | |
| c.1808G>A | p.Arg603Gln | missense_variant | Familial | Paternal | Multiplex | 33004838 | Wang T et al. (2020) | |
| c.675del | p.Phe226LeufsTer19 | frameshift_variant | Unknown | Not maternal | - | 33004838 | Wang T et al. (2020) | |
| c.1106_1107insG | p.Leu370SerfsTer21 | frameshift_variant | Familial | Maternal | Simplex | 36309498 | Chan AJS et al. (2022) |
Common Variants
No common variants reported.
SFARI Gene score
Suggestive Evidence

Score Delta: Score remained at 3
criteria met
See SFARI Gene'scoring criteriaThe literature is replete with relatively small studies of candidate genes, using either common or rare variant approaches, which do not reach the criteria set out for categories 1 and 2. Genes that had two such lines of supporting evidence were placed in category 3, and those with one line of evidence were placed in category 4. Some additional lines of "accessory evidence" (indicated as "acc" in the score cards) could also boost a gene from category 4 to 3.
10/1/2025

Increased from to 3
Krishnan Probability Score
Score 0.60927811408287
Ranking 263/25841 scored genes
[Show Scoring Methodology]
ExAC Score
Score 0.97389993424598
Ranking 2275/18225 scored genes
[Show Scoring Methodology]
Sanders TADA Score
Score 0.94394171593086
Ranking 15882/18665 scored genes
[Show Scoring Methodology]
Zhang D Score
Score -0.006734670735342
Ranking 8897/20870 scored genes
[Show Scoring Methodology]